GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Syngene International Ltd (NSE:SYNGENE) » Definitions » Revenue

Syngene International (NSE:SYNGENE) Revenue : ₹34,886 Mil (TTM As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Syngene International Revenue?

Syngene International's revenue for the three months ended in Mar. 2024 was ₹9,169 Mil. Its revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₹34,886 Mil. Syngene International's Revenue per Share for the three months ended in Mar. 2024 was ₹22.85. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹86.78.

Good Sign:

Syngene International Ltd has shown predictable revenue and earnings growth.

During the past 12 months, the average Revenue per Share Growth Rate of Syngene International was 9.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was 18.50% per year. During the past 5 years, the average Revenue per Share Growth Rate was 16.10% per year. During the past 10 years, the average Revenue per Share Growth Rate was 16.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Syngene International's highest 3-Year average Revenue per Share Growth Rate was 25.30% per year. The lowest was 12.90% per year. And the median was 18.50% per year.


Syngene International Revenue Historical Data

The historical data trend for Syngene International's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syngene International Revenue Chart

Syngene International Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18,797.00 20,891.00 25,067.00 31,929.00 34,886.00

Syngene International Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9,944.00 8,081.00 9,101.00 8,535.00 9,169.00

Competitive Comparison of Syngene International's Revenue

For the Biotechnology subindustry, Syngene International's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Syngene International's Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Syngene International's Revenue distribution charts can be found below:

* The bar in red indicates where Syngene International's Revenue falls into.



Syngene International Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹34,886 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Syngene International  (NSE:SYNGENE) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Syngene International Revenue Related Terms

Thank you for viewing the detailed overview of Syngene International's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Syngene International (NSE:SYNGENE) Business Description

Traded in Other Exchanges
Address
Jigani Link Road, Biocon SEZ, Biocon Park, Plot No. 2 and 3, IV Phase, Bommasandra Industrial Area, Bangalore, KA, IND, 560 099
Syngene International Ltd is a contract research and manufacturing organization in India. It supports research and development programs, from lead generation to clinical and commercial supplies. The company operates in India, the United States of America and other countries, of which a majority of the revenue is derived from the US. The company receives revenue by providing contract research and manufacturing services. It offers services such as Oligonucleotide synthesis, Bioinformatics, Clinical development services, polymer research, chemical development, safety assessment, discovery chemistry, discovery biology, and others.

Syngene International (NSE:SYNGENE) Headlines

No Headlines